Arax Advisory Partners’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-102	Closed	-$357	–	2523
2024 Q3	$357	Hold	102	–	–	﹤0.01%	2450
2024 Q2	$335	Buy	+102	New	+$335	﹤0.01%	2382